Evelo Biosciences Overview
Latest P/E ratio for Evelo Biosciences: 0.0 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow0.00
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
As of the most recent data, EVLO shows a P/E ratio of 0.0. That is below the Healthcare sector average of 25.9. Scroll down for historical charts and peer comparison views.
The Healthcare sector average P/E ratio is about 25.9. Evelo Biosciences is at 0.0, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how EVLO stacks up against individual peers as well.
Investors watch EVLO's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Evelo Biosciences's latest reading is 0.0. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this p/e ratio page, Stockcircle has Evelo Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently 0.0) with ownership activity and broader fundamentals.
The Healthcare average P/E ratio is about 25.9, while EVLO is at 0.0. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
